Ajanta Pharma rose 0.54% to Rs 55.35 at 13:00 IST on BSE, as net profit surged 53.74% to Rs 4.32 crore in Q2 September 2008 over Q2 September 2007.
The stock hit a high of Rs 57 and a low of Rs 53 so far during the day. The stock has a 52-week high of Rs 125.50 on 8 January 2008 and a 52-week low of Rs 51.50 on 22 October 2008.
The stock had declined sharply ahead of the results, plunging 9.16% to Rs 55.05 on 22 October 2008, from a recent high of Rs 60.60 on 15 October 2008.
The company’s current equity is Rs 11.86 crore. Face value per share is Rs 10.
The current price of Rs 55.35 discounts the company’s Q1 June 2008 annualized EPS of Rs 10.68, by a PE multiple of 5.18.
Ajanta Pharma’s net sales rose 23.16% to Rs 88.38 crore in Q2 September 2008 over Q2 September 2007.
Ajanta Pharma is well established in therapeutic segments like dermatology, cardiology, and ophthalmology.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment